The UK breakthrough cancer pain registry: origin, methods and preliminary data

@article{Ward2011TheUB,
  title={The UK breakthrough cancer pain registry: origin, methods and preliminary data},
  author={Jennifer Ward and Barry J Laird and Marie Fallon},
  journal={BMJ Supportive \& Palliative Care},
  year={2011},
  volume={1},
  pages={A24 - A24}
}
Abstract Introduction and aims Breakthrough cancer pain (BTcP) is a debilitating element of cancer pain. Rapidly absorbed formulations of fentanyl, such as fentanyl sublingual tablets (FST, Abstral, proStrakan, Galashiels, UK), are well matched to the rapid onset and short duration of BTcP episodes. Only limited data are available on the use of such agents outside clinical trials. The UK BTcP Registry was initiated to record patients' and clinicians' experiences of titration and treatment with… Expand
2 Citations
Successful Dose Finding with Sublingual Fentanyl Tablet: Combined Results from 2 Open‐Label Titration Studies
Objective:  This analysis was conducted to determine the likelihood of identifying an effective dose of fentanyl sublingual tablet during the initial titration phase of 2 clinical trials, toExpand